Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2001
06/27/2001CN1301175A Humanized antibodies that recognize verotoxin II and cell line producing same
06/27/2001CN1301131A Dipeptide apoptosis inhibitors and the use thereof
06/27/2001CN1300852A DNA sequence for coding human lysozyme gene and its application
06/27/2001CN1067726C Monoclonal antibody for recognizing interstitial cell surface antigen
06/27/2001CN1067550C Calcium receptor active molecules
06/26/2001US6252139 Generating genetically engineered plants; incubate cells with nucleotide sequence coding cyclin protein, transform cells, propagate cells, isolate plants with amplified root propagation
06/26/2001US6252138 Nucleotide sequences coding nematocide; for the production of disease resistant plants
06/26/2001US6252136 Transgenic organisms having tetracycline-regulated transcriptional regulatory systems
06/26/2001US6252134 Generating plant with amplified baked goods qualities; transform wheat cell, propagate cell, recover wheat plants
06/26/2001US6252133 Regenerating embryo of mammal; transfer nucleus of diploid cell into oocyte, activate and develop embryo
06/26/2001US6252130 Production of somatic mosaicism in mammals using a recombinatorial substrate
06/26/2001US6252051 ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor
06/26/2001US6252050 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
06/26/2001US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells
06/26/2001US6251871 Administering pharmaceutical composition comprising adenoviral vector comprising promoter functional in eukaryotic cells and nucleic acid encoding p16 and buffer, solvent or diluent to mammal to inhibit tumor growth
06/26/2001US6251859 Deepithelialized skin diffusion cell system
06/26/2001US6251672 Culturing mammalian cells in contact with cell surface proteins
06/26/2001US6251671 Culturing mammalian spermatogonial stem cells with bone morphogenetic protein 8 to cause proliferation of the stem cells and survival of spermatocytes
06/26/2001US6251670 Method of culturing cells in suspension using lectins
06/26/2001US6251669 Mammalian, non-tumor derived cells which divide, express neuron-specific markers, and give rise to progeny which differentiate into neuronal cells; for transplantation in treatment of alzheimer's/parkinson's diseases
06/26/2001US6251665 Producing cancer-specific cells by isolating cd34 positive hematopoietic stem cells, incubating in cell culture medium, mixing with tumor cell material, and incubating with tumor necrosis factor-alpha
06/26/2001US6251645 Leflunomide-resistant helicase; anticarcinogenic agents; antidiabetic agents; immunosuppressants; treatment of alzheimer's disease, atherosclerosis, osteoporosis, autoimmune disorders, and rheumatoid arthritis
06/26/2001US6251640 Genetically engineered virus having tata element promoter, tet operator sequence, and a gene which inhibits replication of virus when expressed; gene therapy; vaccines; viricides
06/26/2001US6251628 Isolated nucleic acid molecules encoding Smad7
06/26/2001US6251627 Antigen presenting system and methods for activation of T-cells
06/26/2001US6251617 Screening for modulators of glycine transport; incubate cells with modulator and measure amount of glycine transport activity
06/26/2001US6251612 Hybridoma; cheap and sensitive monitoring of water pollution
06/26/2001US6251603 Evaluating cancer in humans; detect preferential gene expression in tumor, mix sample with antibodies which bind preferential protein, count amount of protein, an amplified protein value indicates adjustment in cancer classification
06/26/2001US6251590 Differential Qualitative screening
06/26/2001US6251438 Method of preparing active substances from nacre, products obtained which can be used in particular as medicaments
06/26/2001US6251398 Fusion proteins comprising transport proteins comprising sequences from herpesviral vp22 or fragments thereof together with an antigenic sequence greater than 12 amino acids in length
06/26/2001US6251385 Antigen stimulated cells for cancer treatment, free of bodily fluids
06/26/2001US6251384 Metastasis models using green fluorescent protein (GFP) as a marker
06/26/2001US6251383 Method for ex-vivo expansion of hematopoietic cells
06/26/2001CA2245461C Detection of conditions or diseases associated with an altered level of telomerase activity
06/26/2001CA1341263C Recombinant fowlpox virus, heterologous protein expression vectors, and fowl vaccines derived from this virus
06/21/2001WO2001044816A2 Conformational and topological protein regulation
06/21/2001WO2001044514A2 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements
06/21/2001WO2001044497A2 Protein kinase regulation
06/21/2001WO2001044483A1 Transgenic insect
06/21/2001WO2001044482A2 Optimized t-dna transfer and vectors therefor
06/21/2001WO2001044481A1 Fusion protein delivery system and uses thereof
06/21/2001WO2001044480A2 Enzymes and genes used for producing vanillin
06/21/2001WO2001044478A2 CORE 1 β3-GALACTOSYL TRANSFERASES AND METHODS OF USE THEREOF
06/21/2001WO2001044472A1 Tnfr/opg-like molecules and uses thereof
06/21/2001WO2001044463A1 Shotgun scanning, a combinatorial method for mapping functional protein epitopes
06/21/2001WO2001044459A2 Method to enhance agrobacterium-mediated transformation of plants
06/21/2001WO2001044458A2 Bovine immunodeficiency virus (biv) based vectors
06/21/2001WO2001044454A2 Root-specific promoter
06/21/2001WO2001044448A2 Human oxidoreductase proteins
06/21/2001WO2001044447A1 Compositions and methods for halogenation reactions
06/21/2001WO2001044445A2 Human lyases and associated proteins
06/21/2001WO2001044442A1 Arginine-enriched medium composition used for mass-producing recombinant protein in animal cell culture
06/21/2001WO2001044441A1 Stabilizing diluent for polypeptides and antigens
06/21/2001WO2001044438A2 Serological diagnostic method with rickettsia pulicis bacterium
06/21/2001WO2001044300A2 Brain specific binding members
06/21/2001WO2001044291A2 Polynucleotid encoding the rg1 polypeptide
06/21/2001WO2001044286A2 Five-helix protein
06/21/2001WO2001044282A2 Bcl-g polypeptides, encoding nucleic acids and methods of use
06/21/2001WO2001044280A2 Methods and compositions for the manufacture of replication incompetent adenovirus
06/21/2001WO2001044246A1 Bicyclic inhibitors of glycogen synthase kinase 3
06/21/2001WO2001043869A2 Cell arrays and the uses thereof
06/21/2001WO2001043763A1 Betaglycan as an inhibin receptor and uses thereof
06/21/2001WO2001043694A2 Compositions and methods for caspase-induced apoptosis
06/21/2001WO2001043540A2 Methods for producing transgenic animals
06/21/2001WO2001043539A1 Animals with insufficient expression of uridine phosphorylase
06/21/2001WO2001019871A3 Delivery system for antidandruff agent
06/21/2001WO2001014535A3 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3
06/21/2001WO2001011051A3 Chimeric proteins
06/21/2001WO2001011034A3 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs
06/21/2001WO2001007607A8 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY
06/21/2001WO2001000795A9 A method for producing cloned cows
06/21/2001WO2000079002A8 Means for identifying the locus of a major resistance gene with respect to the virus of the rice yellow mottle virus and uses thereof
06/21/2001WO2000078972A8 Regulation with binding cassette transporter protein abc1
06/21/2001WO2000075278B1 Gene encoding nade, p75ntr-associated cell death executor and uses thereof
06/21/2001WO2000058472A8 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same
06/21/2001WO2000055345A9 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes
06/21/2001WO2000020574A9 Fusions of scaffold proteins with random peptide libraries
06/21/2001WO2000014212A9 Novel protein kinase molecules and uses therefor
06/21/2001WO1999057246A9 Animal cell culture media comprising non-animal or plant-derived nutrients
06/21/2001WO1998011243A9 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
06/21/2001DE19961519A1 New nucleic acid encoding plant receptor-like protein kinase, useful for identifying new herbicides and growth regulators
06/21/2001DE19960106A1 Enzyme und Gene für die Herstellung von Vanillin Enzymes and genes for the production of vanillin
06/21/2001DE19957470A1 Tetrahydropyrimidin-Dioxygenase-Gen sowie Verfahren zur enzymatischen in vivo und in vitro Produktion von hydroxylierten Tetrahydropyrimidinen Tetrahydropyrimidine dioxygenase gene as well as methods for the enzymatic in vivo and in vitro production of hydroxylated tetrahydropyrimidines
06/21/2001DE19956513A1 Resolvase-katalysierte, Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen Resolvase-catalyzed sequence-specific DNA recombination in eukaryotic cells
06/21/2001DE19956503A1 Spritzbares Knochenersatzmaterial An injectable bone substitute material
06/21/2001CA2641218A1 Hybrid promoter for use in plants
06/21/2001CA2640686A1 Novel plant expression constructs
06/21/2001CA2396654A1 Core 1 .beta.3-galactosyl transferases and methods of use thereof
06/21/2001CA2396539A1 Root-specific promoter
06/21/2001CA2396503A1 Stabilizing diluent for polypeptides and antigens
06/21/2001CA2394840A1 Optimized t-dna transfer and vectors therefor
06/21/2001CA2394600A1 Methods for producing transgenic animals
06/21/2001CA2394576A1 Betaglycan as an inhibin receptor and uses thereof
06/21/2001CA2394574A1 Dna encoding a novel rg1 polypeptide
06/21/2001CA2394536A1 Tnfr/opg-like molecules and uses thereof
06/21/2001CA2394367A1 Method to enhance agrobacterium-mediated transformation of plants
06/21/2001CA2394269A1 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements
06/21/2001CA2394160A1 Human oxidoreductase proteins
06/21/2001CA2394149A1 Serological diagnostic method with rickettsia pulicis bacterium